Skip to main content
. Author manuscript; available in PMC: 2011 Aug 15.
Published in final edited form as: Clin Infect Dis. 2010 Aug 15;51(4):468–471. doi: 10.1086/654797

Table 1.

Clinical Characteristics, Laboratory Results, and Treatment of Ocular Syphilis among Human Immunodeficiency Virus–Infected Patients

Patient Age,
years
CD4+ cell
count,
cells/μL
HIV RNA
copies/
mLa
Serum
RPR
level
CSF VDRL
test result
CSF WBC
count,
cells/μL
Ocular examination result Visual acuity
Antibiotic regimend Syphilis
recurrence
Before
treatmentb
After
treatmentc
1 31 217 25,740 1:256 1:2 141 Panuveitis 20/800 20/63 Intravenous penicillin for 2 weeks, intramuscular penicillin for 3 weeks No

2 38 532 <400 1:128 NR 12 Anterior uveitis Intravenous penicillin for 2 weeks, intramuscular penicillin for 1 week No

3 54 539 <50 1:256 NR 2 Posterior uveitis, optic neuritis 20/80 20/25 Intravenous penicillin for 2 weeks No

4e 41 228 188,000 1:2048 1:2 20 Panuveitis, optic neuritis 20/400 20/20 Intravenous penicillin for 2 weeks Yes

5 52 237 174,000 1:128 NR 1 Anterior uveitis, optic neuritis 20/25 20/20 Intravenous penicillin for 3 weeks No

6 36 745 54,500 1:1024 1:1 12 Panuveitis, optic neuritis CF 20/20 Intravenous penicillin for 2 weeks intramuscular penicillin for 1 week No

7 36 472 <50 1:256 NR 4 Posterior uveitis 20/320 20/25 Intravenous penicillin for 2 weeks, intramuscular penicillin for 3 weeks Yes

8 36 780 3380 1:256 1:4 11 Posterior uveitis Intravenous penicillin for 2 weeks, intramuscular penicillin for 3 weeks No

9f 26 348 1850 1:128 Anterior uveitis 20/20 Intramuscular/intravenous penicillin for 10 days Yes

10 46 599 <50 1:256 NR 5 Anterior uveitis 20/60 20/25 Intramuscular penicillin for 10 days No

11 23 747 240,222 1:512 1:16 187 Anterior uveitis CF 20/40 Intravenous penicillin for 2 weeks No

12 45 305 <48 1:64 NR 3 Optic neuritis 20/20 16/15 Intravenous penicillin for 1 week, oral doxycycline for 28 days No
13 55 142 <48 1:128 NR 1 Panuveitis, optic neuritis 20/200 20/32 Intravenous penicillin for 2 weeks, intramuscular penicillin for 1 week No

NOTE. CSF, cerebrospinal fluid; NR, nonreactive; RPR, rapid plasma reagin; WBC, white blood cell.

a

All 5 patients receiving antiretroviral therapy had viral loads less than the limit of detection.

b

Visual acuity scores of the more severely affected eye; CF, able to count fingers only from ≤3 feet; original reports detailing visual acuity examination unavailable for 2 patients.

c

All posttreatment visual acuities tested within 3 months.

d

Intravenous penicillin dosage was 24 MU daily; intramuscular penicillin, 2.4 MU weekly; oral doxycycline, 200 mg twice daily; patients 9 and 10 were treated with 2.4 MU intramuscular procaine penicillin daily with probenecid 500 mg 4 times per day; patient 9 was switched to intravenous penicillin after the fourth day.

e

Patient described in the case report.

f

Declined lumbar puncture.